Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-22

Clinical Trial Update: Hydroxychloroquine in Colchicine-Resistant Glucocorticoid-Dependent Idiopathic Recurrent Pericarditis [Phase 3]

View source ↗

Summary

Phase 3 trial update exploring hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis (pericarditis idiopathic r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Hippocration General Hospital | Conditions: Pericarditis Idiopathic Recurrent | Phase 3 | Status: UNKNOWN